Cícera Datiane de Morais Oliveira-Tintino

Dr. Cícera Datiane de Morais Oliveira-Tintino

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Phytomedicine
Verified
Journal Article
Closed access
Cícera Datiane de Morais Oliveira-TintinoCícera Datiane de Morais Oliveira-Tintino
Cícera Datiane de Morais Oliveira-Tintino
RPRenata Torres Pessoa
Renata Torres Pessoa
MFMaria Neyze Martins Fernandes
Maria Neyze Martins Fernandes
IAIsabel Sousa Alcântara
Isabel Sousa Alcântara
BSBruno Anderson Fernandes da Silva
Bruno Anderson Fernandes da Silva
Irwin Rose Alencar de MenezesIrwin Rose Alencar de Menezes
Irwin Rose Alencar de Menezes

22 June 2021 in Journal of Bioenergetics and Biomembranes
Verified
Journal Article
Closed access
PDF file
CBCristina Rodrigues Dos Santos Barbosa
Cristina Rodrigues Dos Santos Barbosa
JSJackelyne Roberta Scherf
Jackelyne Roberta Scherf
TFThiago Sampaio de Freitas
Thiago Sampaio de Freitas
Irwin Rose Alencar de MenezesIrwin Rose Alencar de Menezes
Irwin Rose Alencar de Menezes
RPRaimundo Luiz Silva Pereira
Raimundo Luiz Silva Pereira
FCFrancisco Cunha
Francisco Cunha

25 June 2020 in Membranes
Verified
Journal Article
Open access
PDF file
Saulo TintinoSaulo Tintino
Saulo Tintino
VSVeruska C. A. de Souza
Veruska C. A. de Souza
JSJulia M. A. da Silva
Julia M. A. da Silva
Cícera Datiane de Morais Oliveira-TintinoCícera Datiane de Morais Oliveira-Tintino
Cícera Datiane de Morais Oliveira-Tintino
PPPedro Silvino Pereira
Pedro Silvino Pereira
VBValdir Q. Balbino
Valdir Q. Balbino
Resistance to antibiotics has made diseases that previously healed easily become more difficult to treat. Staphylococcus aureus is an important cause of hospital-acquired infections and multi-drug resistant. NorA efflux pump, present in bacteria S. aureus, is synthesized by the expression of the norA gene. Menadione, also known as vitamin K3, is one of the synthetic forms of vitamin K. Therefore, the aim of this study is to verify the menadione effect on efflux inhibition through NorA pump gene expression inhibition and assess the effects of menadione in bacterial membrane. The effect of menadione as an efflux pump inhibitor (EPI) was evaluated by the microdilution method, fluorimetry, electron microscopy, and by RT-qPCR to evaluate gene expression. In the molecular docking, association with menadione induces increased fluorescence intensity. Menadione was observed (100% of the clusters) interacting with residues ILE12, ILE15, PHE16, ILE19, PHE47, GLN51, ALA105, and MET109 from NorA. The results showed the norA gene had its expression significantly diminished in the presence of menadione. The simulation showed that several menadione molecules were able to go through the bilayer and allow the entry of water molecules into the hydrophobic regions of the bilayer. When present within membranes, menadione may have caused membrane structural changes resulting in a decline of the signaling pathways involved in norA expression. Menadione demonstrated to be an efflux pump inhibitor with dual mechanism: affecting the efflux pump by direct interaction with protein NorA and indirectly inhibiting the norA gene expression, possibly by affecting regulators present in the membrane altered by menadione.

4 December 2024 in Antibiotics
Verified
Journal Article
Open access
PDF file
JAJosé Weverton Almeida-Bezerra
José Weverton Almeida-Bezerra
Saulo Almeida MenezesSaulo Almeida Menezes
Saulo Almeida Menezes
JSJosé Thyálisson da Costa Silva
José Thyálisson da Costa Silva
SSSimone Galdino de Sousa
Simone Galdino de Sousa
DADaniel Sampaio Alves
Daniel Sampaio Alves
HCHenrique Coutinho
Henrique Coutinho
Background: Phytol is a diterpene from the long-chain unsaturated acyclic alcohols, known for its diverse biological effects, including antimicrobial and anti-inflammatory activities. Present in essential oils, phytol is a promising candidate for various applications in the pharmaceutical and biotechnological sectors. This study aimed to evaluate the in vitro antibacterial and drug-potentiating effects of phytol against multidrug-resistant bacteria and to evaluate its in silico properties: ADME and molecular docking. Methods: The in vitro antibacterial activity of phytol and the phytol combined with conventional drugs was evaluated by microdilution tests against standard and resistant bacterial strains. Finally, the SwissADME platform was employed to analyse the physicochemical and pharmacokinetic characteristics of phytol. Results: Phytol significantly reduced the Minimum Inhibitory Concentration (MIC) of norfloxacin and gentamicin required to inhibit multidrug-resistant strains of Escherichia coli and Staphylococcus aureus, respectively. Additionally, ADME analysis revealed that phytol exhibits low toxicity and favourable pharmacokinetic properties; in addition, it is revealed through molecular docking that phytol showed a relevant affinity with the proteins 6GJ1 and 5KDR, however, with values lower than the drugs gentamicin and ampicillin. Conclusions: Collectively, these findings suggest that phytol holds potential as an effective adjuvant in combating antimicrobial resistance.

28 September 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Cícera Datiane de Morais Oliveira-TintinoCícera Datiane de Morais Oliveira-Tintino
Cícera Datiane de Morais Oliveira-Tintino
JSJorge Ederson Gonçalves Santana
Jorge Ederson Gonçalves Santana
GAGabriel Gonçalves Alencar
Gabriel Gonçalves Alencar
GSGustavo Miguel Siqueira
Gustavo Miguel Siqueira
SGSheila Alves Gonçalves
Sheila Alves Gonçalves
HCHenrique Coutinho
Henrique Coutinho
Valencene and nootkatone are aromatic sesquiterpenes with known biological activities, such as antimicrobial, antioxidant, anti-inflammatory, and antitumor. Given the evidence that encapsulation into nanosystems, such as liposomes, could improve the properties of several compounds, the present study aimed to evaluate the activity of these sesquiterpenes in their isolated state or in liposomal formulations against strains of Staphylococcus aureus carrying efflux pumps. The broth microdilution method evaluated the antibiotic-enhancing activity associated with antibiotics and ethidium bromide (EtBr). The minimum inhibitory concentration was assessed in strains of S. aureus 1199B, IS-58, and RN4220, which carry the efflux proteins NorA, Tet(K), and MsrA. In tests with strain 1199B, valencene reduced the MIC of norfloxacin and EtBr by 50%, while the liposomal formulation of this compound did not show a significant effect. Regarding the strain IS-58, valencene, and its nanoformulation reduced norfloxacin MIC by 60.3% and 50%, respectively. In the non-liposomal form, the sesquiterpene reduced the MIC of EtBr by 90%. Against the RN4220 strain, valencene reduced the MIC of the antibiotic and EtBr by 99% and 93.7%, respectively. Nootkatone and its nanoformulation showed significant activity against the 1199B strain, reducing the EtBr MIC by 21.9%. Against the IS-58 strain, isolated nootkatone reduced the EtBr MIC by 20%. The results indicate that valencene and nootkatone potentiate the action of antibiotics and efflux inhibitors in strains carrying NorA, Tet(K), and MsrA proteins, which suggests that these sesquiterpenes act as efflux pump inhibitors in S. aureus. Therefore, further studies are needed to assess the impact of incorporation into liposomes on the activity of these compounds in vivo.

17 November 2023 in Molecules
Verified
Journal Article
Open access
PDF file
JSJorge Ederson Gonçalves Santana
Jorge Ederson Gonçalves Santana
Cícera Datiane de Morais Oliveira-TintinoCícera Datiane de Morais Oliveira-Tintino
Cícera Datiane de Morais Oliveira-Tintino
GAGabriel Gonçalves Alencar
Gabriel Gonçalves Alencar
GSGustavo Miguel Siqueira
Gustavo Miguel Siqueira
DADaniel Sampaio Alves
Daniel Sampaio Alves
TGTeresinha Gonçalves-Silva
Teresinha Gonçalves-Silva
The efflux systems are considered important mechanisms of bacterial resistance due to their ability to extrude various antibiotics. Several naturally occurring compounds, such as sesquiterpenes, have demonstrated antibacterial activity and the ability to inhibit efflux pumps in resistant strains. Therefore, the objective of this research was to analyze the antibacterial and inhibitory activity of the efflux systems NorA, Tet(K), MsrA, and MepA by sesquiterpenes nerolidol, farnesol, and α-bisabolol, used either individually or in liposomal nanoformulation, against multi-resistant Staphylococcus aureus strains. The methodology consisted of in vitro testing of the ability of sesquiterpenes to reduce the Minimum Inhibitory Concentration (MIC) and enhance the action of antibiotics and ethidium bromide (EtBr) in broth microdilution assays. The following strains were used: S. aureus 1199B carrying the NorA efflux pump, resistant to norfloxacin; IS-58 strain carrying Tet(K), resistant to tetracyclines; RN4220 carrying MsrA, conferring resistance to erythromycin. For the EtBr fluorescence measurement test, K2068 carrying MepA was used. It was observed the individual sesquiterpenes exhibited better antibacterial activity as well as efflux pump inhibition. Farnesol showed the lowest MIC of 16.5 µg/mL against the S. aureus RN4220 strain. Isolated nerolidol stood out for reducing the MIC of EtBr to 5 µg/mL in the 1199B strain, yielding better results than the positive control CCCP, indicating strong evidence of NorA inhibition. The liposome formulations did not show promising results, except for liposome/farnesol, which reduced the MIC of EtBr against 1199B and RN4220. Further research is needed to evaluate the mechanisms of action involved in the inhibition of resistance mechanisms by the tested compounds.